Alzheimer's disease, a neurodegenerative disorder, refers to a particular onset and course
of cognitive and functional decline associated with alteration in particular neuropathology …

Approximately 35 million people worldwide suffer from Alzheimer's disease (AD). The
cellular uptake and specific transport of drugs and imaging agents to brain are common …

Alzheimer's disease (AD) is one of the neurodegenerative diseases that leads to the
deposition of amyloid plaques in the neuropil as well as outside the cells in the brain leading …

Alzheimer's disease (AD) is a non-recoverable progressive neurodegenerative disorder
most prevalent but not limited to the old age population. After all the scientific efforts, there …

Alzheimer's disease (AD) is a chronic neurodegenerative disorder associated with
dementia. To overcome the limitations of diagnosis and treatment nanotechnology research …

The present review deals in-depth with the current application of nanotechnology in
targeting the major pathological hallmarks of Alzheimer's disease. This review further …

Recent nanotechnological advancements have opened new windows of hope for the
treatment of neurodegenerative diseases and all of these new methods are rapidly evolving …

Neurodegenerative diseases represent a formidable global health challenge, affecting
millions and imposing substantial burdens on healthcare systems worldwide. Conditions …

Background: Dementia and its related types such as Alzheimer's disease, vascular dementia
and mixed dementia belong to brain associated diseases, resulting in long-term progressive …

Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …